OSTEOPOROSIS Flashcards

1
Q

What are the 3 forms of calcium in the blood?

A

45% Bound to proteins e.g. albumin - not diffusable and not biologically active
40% Free-ionised - this is diffusable and biologically active
15% Bound to anions e.g. phosphate - diffusable but not biologically active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The 3 molecules which regulate the amount of calcium in the blood?

A

Calcitriol (vit D)
Parathyroid hormone
Calcitonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Outline how vitamin D is synthesised?

A

7-dehydrocholesterol is converted into vitamin D3 under the influence of UV radiation.
In the liver, vitamin D3 is converted into 25-hydroxyvitamin-D by 25-hydroxylase. This is relatively inactive.
In the kidney, 1-α-hydroxylase converts 25-hydroxyvitamin-D into 1,25-dihydroxyvitamin-D, otherwise known as calcitriol. This is metabolically active.
Calcitriol is then released into the blood stream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does vitamin D affect calcium levels?

A

Calcitriol stimulates intestinal epithelial cells to increase the synthesis of calbindin-D proteins. These proteins increase intestinal absorption of calcium by facilitating the transport of calcium from the intestines to the blood stream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where is PTH released from?

A

Chief cells of the parathyroid glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does PTH affect calcium levels?

A

It increases them by…
Increasing bone resorption - binds to osteoblasts and upregulates expression of RANKL which stimulates pre-osteoclasts to differentiate into osteoclasts
Increasing renal reabsorption of calcium - upregulates expression of specific channels in DCT
Increasing synthesis of calcitriol - upregulates expression of 1-alpha-hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where is calcitonin secreted from?

A

Parafollicular cells in the thyroid gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does calcitonin affect calcium levels?

A

Decreases them by inhibiting osteoclasts = reduces bone resorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is osteomalacia?

A

Softening of the bones secondary to low vitamin D levels = decreased bone mineral content

(Aka rickets in children)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Causes of osteomalacia?

A

Vitamin D deficiency (malabsorption, lack of sunlight, diet)
CKD
Drug induced e.g. AEDs
Inherited - hypophosphataemic rickets
Severe liver disease
Coeliac disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathophysiology of osteomalacia?

A

Vitamin D deficiency = lack of calcium and phosphate absorption intestines and reabsorption in kidneys = low calcium and phosphate = defective bone mineralisation = increased PTH secretion by parathyroid glands = increased calcium reabsorption from bones further impairing bone mineralisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Presentation of osteomalacia?

A

Bone pain
Bone and muscle tenderness
Fractures - esp femoral neck
Proximal myopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Investigations for osteomalacia?

A

Bloods - vit D and bone profile, LFTs (for ALP) and PTH levels
XR
DEXA scan

(May also try to find cause e.g. U&Es, TFT, coeliac serology)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Some individual factors that affect the amount of vitamin D synthesized in the skin?

A

Age - lower serum 25-hydroxyvitamin D concentrations in older people
Skin colour - melanin pigment absorbs a proportion of UVB radiation so people with darker skin may need more sunlight exposure to produce the same amount of vitamin D as those with lighter skin
Clothing cover
Sunscreen use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Risk factors for vitamin D defieicny?

A

Aged over 65
Low or no sun exposure e.g. cover skin, house bound
Darker skin pigmentation
GI or malabsorption disorder
Severe liver disease
CKD
Certain drugs e.g. AED
Pregnant or breastfeeding
Obese

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Vitamin D, calcium, phosphate and ALP levels in pts with osteomalacia?

A

Low vit D
Low calcium
Low phosphate in most
Raised ALP due to increased osteoblasts activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

XR findings in osteomalacia?

A

Diffuse demineralisation
Insufficiency fractures - looser zones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are looser zones?

A

Pseudofractures - a thin translucent band that runs perpendicular to the surface of the bone extending from the cortex inwards
They are incomplete stress fractures which heal with callus lacking in Ca
Most common in pubic rami, neck of humerus/femur, and axillary edge of scapulae

Seen in osteomalacia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Management of osteomalacia?

A

Vitamin D supplementation - usually a loading regime and then a maintenance dose
Calcium supplementation if dietary calcium is inadequate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is osteoporosis?

A

A significant reduction in bone density making them weaker and prone to fractures
When bone mineral density is less than 2.5 standard deviations below the young adult mean density

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is osteopenia?

A

When bone mineral density is 1-2.5 SD below ythe young adult mean density
I.e. low BMD but not low enough to be classed as osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are fragility fractures?

A

Pathological fractures that result from low energy trauma
Usually hip, distal radius or spine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Risk factors for osteoporosis?

A

Older age
Female gender. Particularly post-menopausal women
Reduced mobility and activity
Low BMI (under 19 kg/m2)
Low calcium or vitamin D intake
Alcohol and smoking
Personal or family history of fractures
Chronic diseases (e.g. CKD and RA)
Long-term corticosteroids (e.g., 7.5mg or more of prednisolone daily for longer than 3 months)
Certain medications (e.g., SSRIs, PPIs, anti-epileptics and anti-oestrogens)
Sedentary lifestyle
Premature menopause
Endocrine disorders - hyperthyroidism, hypogonadism, GH deficiency, DM, hyperparathyroidism
Multiple myeloma and lymphoma
GI disorders - IBD and coeliac
Osteogenesis imperfecta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Screening tools used in osteoporosis?

A

FRAX or QFracture - assess the 10 year risk of a pt developing a fragility fracture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How is bone mineral density assessed?

A

Using a Dual-energy X-ray Absorptiometry scann that looks at the hip and lumbar spine

26
Q

How do we interpret DEXA scan results?

A

They produce either a Z-score or a T-score
A Z-score is the number of SD the pt is from the average for their age, sex and ethnicity
The T-score is the number of SD that the pt is from an average healthy young adult - this is the score used to make the diagnosis

27
Q

How does a DEXA scan work?

A

X-rays are used and detectors measure how much radiation passes through the bones and calculate a bone density score

28
Q

How to interpret T scores from a DEXA scan?

A

> -1.0 = normal
-1.0 to -2.5 = osteopaenia
< -2.5 = osteoporosis

29
Q

Epidemiology of osteoporosis?

A

F:M 6:1
Prevalence in women its at 2% at 50 years, and >25% at 80 years

30
Q

Medications that can worsen osteoporosis?

A

Steroids
SSRIs
AEDs
PPIs
Glitazones
Long term heparin therapy
Aromatase inhibitors e.g. anastrazole

31
Q

Investigtaions for osteoporosis?

A

FBC, U&Es, CRP, bone profile, albumin, LFTs, TFTs
DXA scan

Others may be indicated e.g. PTH, protein immunoelectrophoresis, serum testosterone, urinary calcium

32
Q

What amount of steroid is thought to significant raise the risk of osteoporosis?

A

Taking the equivalent of 7.5mg a day of pred for 3 or more months

33
Q

Who should be assessed for osteoporosis?

A

Women >65 and Men >75

Younger pt with risk factors e.g. previous fragility fracture, use of steroids, history of falls, FHx of hip fractures, low BMI, smokers, high alcohol intake

34
Q

What is the FRAX score?

A

This estimates the 10 year risk of a fragility fracture occurring
Its valid for pt aged 40-90
It is based on international data so the use is not limited to UK patients
It assesses age, sex, weight, height, fractures, parental fractures, current smoking, steroids, RA, secondary osteoporosis, alcohol intake
You can but BMD into the data which improves the accuracy but this requires a DEXA scan before

35
Q

Interpreting the FRAX score?

A

If done without BMD it will be categorised as…
Low risk - reassure and give lifestyle advice
Intermediate risk - offer BMD test
High risk - offer bone protection Tx

If done with a BMD it will be categorised as…
Reassure
Consider Tx
Strongly recommend Tx

36
Q

Managing a pt following a fragility fracture?

A

For pt who had a fragility fracture…
>=75 - presumed to have underlying osteoporosis so Tx
If <75 then arrange a DEXA scan, enter into FRAX score and this will determine Tx

37
Q

Presentation of osteoporotic vertebral fractures?

A

Often asymptomatic and found incidentally
Acute back pain
Breathing difficulties
GI problems due to compression of abdominal organs
Falls/trauma
Loss of height
Kyphosis
Localised tenderness on palpation of spinous processes at the fracture site

38
Q

XR of spine findings in osteoporotic vertebral fractures?

A

Wedging of vertebrae
May also show old fractures which appear sclerotic

39
Q

What is secondary osteoporosis?

A

Decreased BMD or fragility fractures affecting people who have a secondary cause for bone loss e.g. CKD, coeliac, hyperthyroidism, drugs

40
Q

Describe bone mineral density over the ages in men and women?

A

In childhood and adolescence BMD rapidly increases and reaches the peak by 20-30. Men reach a higher peak than women
After this BMD remains relatively stable provided bone formation and resorption is maintained e.g. weight bearing exercises and sufficiency vitamin D & Ca intake
After the age of 30 BMD declines gradually.
After menopause women experience a significant drop in BMD
In later adulthood men and women continue to experience a gradual decline in BMD. The decline is generally more gradual and starts later than in women

41
Q

Why does menopause significantly impact BMD?

A

Oestrogen inhibits osteoclasts and stimulates osteoblasts
When oestrogen levels decline at menopause the balance between bone formation and resorption is disrupted and there is an increase in osteoclast activity = greater risk of osteoporosis

42
Q

In which pt is treatment for osteoporosis indicated?

A

Following osteoporotic fragility fractures in post-menopausal women confirmed with osteoporosis OR pts over 75

43
Q

Why can 25% of patients not tolerate alendronate?

A

Due to upper GI problems - indigestion or oesophagitis

44
Q

management of osteoporosis?

A

Lifestyle changes - increase physical activity, stop smoking, maintain normal BMI, reduce alcohol
Adequate intake of Ca and vit D - supplements may be necessary
Bisphosphonates - oral alendronate or risedronate sodium are first line
HRT may be considered in post menopausal women

Others: raloxifene, strontium ranelate, denosumab, teriparatide

45
Q

How do bisphosphonates work?

A

They are analogues of pyrophosphate which is a molecule that decreases demineralisation in bone by inhibiting osteoclasts

46
Q

Which bisphosphonates can be given IV?

A

Zoledronic acid - once yearly

47
Q

How should oral bisphosphonates be taken?

A

On an empty stomach with a full glass of water
After the pt should sit upright for 30 mins to reduce risk of reflux and oesophageal erosions

48
Q

Side effects of bisphosphonates?

A

Oesopheagitis and oesophageal ulcers
Osteonecrosis of the jaw - esp with IV bisphosphonates
Increased risk of atypical stress fractures
Acute phase response following administartion e.g. fever, myalgia, arthralgia
Osteonecrosis of the external auditory canal - ear infection Sx

49
Q

Duration of bisphosphonate treatment?

A

Varies according to the level of risk
Some recommend stopping them at 5 years if pt is <75, femoral neck T-score is >-2.5 and low risk according to FRAX

50
Q

Why can bisphosphonate treatment cause atypical fractures?

A

As bisphosphonates cause bone to harden but alter the cortical composition which makes them more brittle

51
Q

which bisphosphonates are most likely to cause oesophagitis?

A

Oral alendronic acid

52
Q

What is Osteonecrosis of the jaw?

A

A severe bone disease that causes death of the jaw - causes exposure of mandibular or maxillary bone through lesions in the gingiva
Its most frequent after invasive dental procedures (so before pts go on bisphosphonates they will have to have any pending dental procedures asap)
It is associated with bisphosphonate therapy

53
Q

What is Paget’s disease of the bone?

A

A disease of increased, uncontrolled bone turnover
Its a disorder of osteoclasts - excessive osteoclastic resorption

Its common in the UK but only symptomatic in 1 in 20 pt

54
Q

Where in the body is Paget’s disease most likely?

A

Skull
Spine
Pelvis
Long bones of lower extremities

55
Q

Risk factors for Paget’s disease?

A

Older age
Male
Northern latitude
FHx

56
Q

Clinical features of Paget’s disease?

A

Older male with bone pain and isolated raised ALP
Bone pain is commonly pelvic, lumbar spine and femur
If untreated it can cause bowing of the tibia and bossing of the skull

57
Q

Investigtaions for Paget’s disease?

A

Bloods - LFTs (raised ALP), bone profile (Ca and phos normal)
Other markers of bone turnover e.g. PINP, CTx, NTx, urinary hydroxyproline
XR - osteolysis and changes in skull XR e.g. thickened vault
Bone scintigraphy - increased uptake will be seen focally at sites of active bone lesions

58
Q

Indications for treating Paget’s disease?

A

Bone pain
Skull or bone deformity
Fractures
Periarticular pagets

59
Q

Management of Paget’s disease?

A

Bisphosphonates

60
Q

Complications of Paget’s disease?

A

Deafness - CN entrapment
Bone sarcoma
Fractures
Skull thickening
High-output HF

61
Q

Pagets vs osteoporosis?

A

Osteoporosis causes thin, fragile bones
Paget’s disease causes enlarged, deformed bones